Leading climate investors are supporting Modern Synthesis’ revolutionary biomaterial technology, which aims to cut emissions and reduce plastic pollution across the fashion, footwear, and automotive industries. Biotechnology innovator Modern Synthesis has successfully closed an oversubscribed $5.5 million funding round to advance the commercialisation of its microbially-derived biomaterials.
No responses yet